Pharmaceuticals Head to Orbit as Private Capital Takes Over

Varda Space Industries' partnership with United Therapeutics marks a watershed moment for commercial space: for the first time, a major publicly traded pharmaceutical company is funding space-based drug manufacturing from its own balance sheet rather than relying on NASA subsidies. This signals growing industry confidence that microgravity-enabled manufacturing can deliver tangible commercial benefits—better drug crystallization, improved stability, and novel delivery methods—transforming the orbital economy from government-dependent research into a self-sustaining commercial enterprise.